[女性的生理和药理特征]
概括
本综述强调了性别特异性的生理和药理差异,强调了它们在医学中的临床相关性. 了解这些变异对于个性化诊断,更安全的药物治疗和改善患者结果至关重要.
科学领域:
- 生理学 生理学 生理学
- 药理学 药理学是指药理学的学科.
- 性别特异医学性别特异医学
背景情况:
- 从历史上看,女性在医学研究和实践中经常被忽视为"偏离规范".
- 性别特异医学通过系统地研究生理和药理差异来解决这些知识差距.
- 这些差异涵盖内分泌,代谢,免疫和药物动力学/药物动力学系统.
研究的目的:
- 总结有关生理学和药理学性别特异性的当前知识.
- 讨论诊断,治疗和预防方面的这些差异的临床相关性.
- 突出将这些差异纳入临床实践和研究的必要性.
主要方法:
- 文学搜索,包括评论文章和初级研究.
- 系统地记录关键生理系统中的性别特异性差异.
- 激素 (雌激素,孕) 对新陈代谢和血管度的影响的分析.
主要成果:
- 性别影响血液学,平衡和免疫反应,影响临床决策.
- 女性的荷尔蒙波动会影响新陈代谢,血管健康和炎症过程.
- 药物的生物可用性,分布,新陈代谢和清除的差异需要个性化剂量和风险评估.
结论:
- 考虑到性别特异性差异可以改善外科手术期间的护理,紧急医疗和疼痛管理.
- 通过考虑这些变化,可以实现个性化诊断,更安全的药物治疗和优化止痛.
- 未来将其纳入指南和临床研究是必不可少的,以尽量减少性别特异性结果差异.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
Factors Affecting Drug Biotransformation: Biological
513
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
513
Factors Affecting Drug Distribution: Physiological Barriers
677
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
677
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235


